UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 21, 2018
Accession Number:
0001193125-18-348294
Submission Type:
POS AM
CIK:
0001114220
Company Name:
KERYX BIOPHARMACEUTICALS INC
File Number:
333-113654